Event Details

Disclosure Type: Regulatory filing pursuant to Regulation 30 read with Part A of Schedule III of SEBI Listing Regulations

Meeting Logistics

The 21st Annual General Meeting of Suraksha Diagnostic Limited was held on Tuesday, 22nd September, 2026 through video conferencing/other audio-visual means (VC/OAVM) in compliance with MCA and SEBI circulars, Companies Act, 2013, and SEBI Listing Regulations.

The meeting commenced at 11:30 A.M. (IST) and concluded at 12:35 P.M. (IST), including the time allowed for e-voting.

Attendance

Dr. Somnath Chatterjee, Chairman of the Company, presided over the meeting and declared it duly convened after confirming requisite quorum.

All Directors attended except Mr. Satish Kumar Verma (Non-Executive Non-Independent Director, DIN: 00225444) who could not attend due to personal reasons.

Key attendees included:

  • Mr. Dinesh Gupta, Chief Financial Officer (CFO)
  • Ms. Ritu Mittal, Joint Managing Director & CEO (DIN: 00165886)
  • Representatives of Secretarial Auditors
  • Ms. Sandhya Malhotra, Practicing Company Secretary and Partner at M/s Manish Ghia and Associates, who served as Scrutinizer

Statutory Auditors were granted leave of absence.

Proceedings Summary

Ms. Ritu Mittal, CEO, briefed members about the affairs of the Company. Mr. Dinesh Gupta, CFO, highlighted the financial performance and growth during Financial Year 2025-26.

With members' consent, the Notice convening the AGM, Auditors' Report, and Secretarial Audit Report for the financial year ended 31st March, 2026 were taken as read.

Statutory Registers and relevant documents were accessible in electronic mode throughout the meeting, including the certificate from the Secretarial Auditor under Regulation 13 of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Resolutions Passed

All five resolutions were passed by members by requisite majority:

Ordinary Business:

1. Adoption of audited standalone financial statements for FY 2025-26 together with Reports of Board of Directors and Auditors

2. Adoption of audited consolidated financial statements for FY 2025-26 together with Report of Auditors

3. Declaration of final dividend of ₹0.50 (Fifty Paise only) per equity share of ₹2 each, representing 25% for financial year ended 31st March, 2026

4. Re-appointment of Mr. Satish Kumar Verma (DIN: 00225444) as Non-Executive Non-Independent Director who retires by rotation

Special Business:

5. Ratification of remuneration payable to M/s. S. Chhaparia & Associates, Cost Auditor for financial year ending 31st March, 2027

Shareholder Engagement

Registered speaker shareholders were invited to raise queries or offer suggestions pertaining to the resolutions. Ms. Ritu Mittal responded to all queries and clarifications sought by members.

Voting and Disclosure

NSDL e-Voting platform remained open for 15 minutes during the meeting for members who had not cast votes through remote e-voting.

The voting results along with scrutinizer's report will be submitted to BSE Limited and National Stock Exchange of India Limited, and made available on the Company's website (www.surakshanet.com) and NSDL's website (www.evoting.nsdl.com).

The recording of the meeting will be made available on the Company's website.